Company Filing History:
Years Active: 2021
Title: James Fairman: Innovator in Nanopore Protein Conjugates
Introduction
James Fairman is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of biotechnology, particularly in the area of DNA sequencing. His innovative work has led to the development of unique nanopore protein conjugates that have the potential to revolutionize sequencing technologies.
Latest Patents
Fairman holds a patent for "Nanopore protein conjugates and uses thereof." This patent describes nanopore protein conjugates that can be utilized in DNA sequencing reactions. The conjugates consist of a nanopore protein monomer that is linked to a DNA binding domain. The nanopore protein monomer is designed to oligomerize with other monomers, while the DNA binding domain effectively binds to a template DNA strand. In specific examples, the nanopore protein monomer is identified as an alpha-hemolysin monomer or a variant, and the DNA binding domain is an Sso7d protein or a variant, such as an Sso7d-like protein. The patent also details nanopore protein assemblies that incorporate these conjugates, along with methods for using them in sequencing reactions. Fairman has 1 patent to his name.
Career Highlights
Throughout his career, Fairman has worked with prominent companies in the biotechnology sector. He has been associated with Roche Sequencing Solutions, Inc. and Genia Technologies, Inc. His experience in these organizations has allowed him to contribute to advancements in sequencing technologies and protein engineering.
Collaborations
Fairman has collaborated with notable colleagues, including Timothy Kellogg Craig and Corissa Harris. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
James Fairman is a distinguished inventor whose work in nanopore protein conjugates has the potential to enhance DNA sequencing methods. His contributions to biotechnology reflect a commitment to innovation and collaboration in the scientific community.